CRESTA, FEDERICO
CRESTA, FEDERICO
A case of interference in testosterone, DHEA-S and progesterone measurements by second generation immunoassays
2021-01-01 Cresta, F.; Arcuri, L.; Bianchin, S.; Castellani, C.; Casciaro, R.; Cavedagna, T. M.; Maghnie, M.; Barco, S.; Cangemi, G.
Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients
2016-01-01 Averna, Monica; Bavestrello, Margherita; Cresta, Federico; Pedrazzi, Marco; DE TULLIO, Roberta; Minicucci, Laura; Sparatore, Bianca; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients.
2013-01-01 Averna, Monica; Pedrazzi, Marco; Minicucci, Laura; DE TULLIO, Roberta; Cresta, Federico; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon
Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study
2024-01-01 Bassi, Marta; Franzone, Daniele; Dufour, Francesca; Spacco, Giordano; Cresta, Federico; D'Annunzio, Giuseppe; Tantari, Giacomo; Calevo, Maria Grazia; Castellani, Carlo; Minuto, Nicola; Casciaro, Rosaria
Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients
2011-01-01 Averna, Monica; Stifanese, Roberto; DE TULLIO, Roberta; Minicucci, Laura; Cresta, Federico; Palena, Serena; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon
Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells
2020-01-01 Scudieri, Paolo; Musante, Ilaria; Venturini, Arianna; Guidone, Daniela; Genovese, Michele; Cresta, Federico; Caci, Emanuela; Palleschi, Alessandro; Poeta, Marco; Santamaria, Francesca; Ciciriello, Fabiana; Lucidi, Vincenzina; Galietta, Luis J V
Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators
2023-01-01 Capraro, Michela; Pedrazzi, Marco; DE TULLIO, Roberta; Manfredi, Marcello; Cresta, Federico; Castellani, Carlo; Averna, Monica
One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study
2024-01-01 Bassi, Marta; Strati, Marina Francesca; Spiandorello, Gaia; Scalas, Marta; Cresta, Federico; Calevo, Maria Grazia; D'Annunzio, Giuseppe; Castellani, Carlo; Minuto, Nicola; Maghnie, Mohamad; Casciaro, Rosaria
Pathological role of the calpain/calpastatin system in cystic fibrosis
2012-01-01 Averna, Monica; Minicucci, Laura; Palena, S.; Cresta, F.; Pontremoli, Sandro; Melloni, Edon
Quantification of Ivacaftor, Tezacaftor and Elexacaftor in plasma of cystic fibrosis patients treated with Kaftrio by a validated liquid chromatography-tandem mass spectrometric (LC-MS/MS) method”
2022-01-01 Cafaro, A.; Pigliasco, F.; Barco, S.; Stella, M.; Pedemonte, N.; Cresta, F.; Casciaro, R.; Castellani, C.; Cangemi, G.; Mattioli, F.
QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD
2023-01-01 Pigliasco, F.; Cafaro, A.; Stella, M.; Baiardi, G.; Barco, S.; Pedemonte, N.; D'Orsi, C.; Cresta, F.; Casciaro, R.; Castellani, C.; Calevo, M. G.; Cangemi, G.; Mattioli, F.
Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background
2023-01-01 Tomati, Valeria; Costa, Stefano; Capurro, Valeria; Pesce, Emanuela; Pastorino, Cristina; Lena, Mariateresa; Sondo, Elvira; Di Duca, Marco; Cresta, Federico; Cristadoro, Simona; Zara, Federico; Galietta, Luis J V; Bocciardi, Renata; Castellani, Carlo; Lucanto, Maria Cristina; Pedemonte, Nicoletta
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method
2023-01-01 Pigliasco, Federica; Cafaro, Alessia; Stella, Manuela; Baiardi, Giammarco; Barco, Sebastiano; Pedemonte, Nicoletta; D'Orsi, Claudia; Cresta, Federico; Casciaro, Rosaria; Castellani, Carlo; Grazia Calevo, Maria; Mattioli, Francesca; Cangemi, Giuliana
The calpain-calpastatin system in cystic fibrosis: physiopathological implications
2011-01-01 Averna, Monica; Grosso, R.; Stifanese, Roberto; Cresta, F.; Minicucci, Laura; Melloni, Edon; Pontremoli, Sandro
The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs
2022-01-01 Sondo, E.; Cresta, F.; Pastorino, C.; Tomati, V.; Capurro, V.; Pesce, E.; Lena, M.; Iacomino, M.; Baffico, A. M.; Coviello, D.; Bandiera, T.; Zara, F.; Galietta, L. J. V.; Bocciardi, R.; Castellani, C.; Pedemonte, N.
The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin
2019-01-01 Furnari, Manuele; De Alessandri, Alessandra; Cresta, Federico; Haupt, Maria; Bassi, Marta; Calvi, Angela; Haupt, Riccardo; Bodini, Giorgia; Ahmed, Iftikhar; Bagnasco, Francesca; Giannini, Edoardo Giovanni; Casciaro, Rosaria
Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica
2023-01-01 Pigliasco, F.; Barco, S.; Pedemonte, N.; Cresta, F.; Casciaro, R.; Castellani, C.; Barbagallo, L.; Maffia, A.; Cangemi, G.; Cafaro, A.
Verso un approccio personalizzato per il trattamento del difetto di base in Fibrosi Cistica
2020-05-20 Cresta, Federico
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A case of interference in testosterone, DHEA-S and progesterone measurements by second generation immunoassays | 1-gen-2021 | Cresta, F.; Arcuri, L.; Bianchin, S.; Castellani, C.; Casciaro, R.; Cavedagna, T. M.; Maghnie, M.; Barco, S.; Cangemi, G. | |
Abnormal activation of calpain and protein kinase Cα promotes a constitutive release of matrix metalloproteinase 9 in peripheral blood mononuclear cells from cystic fibrosis patients | 1-gen-2016 | Averna, Monica; Bavestrello, Margherita; Cresta, Federico; Pedrazzi, Marco; DE TULLIO, Roberta; Minicucci, Laura; Sparatore, Bianca; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon | |
Calpain inhibition promotes the rescue of F(508)del-CFTR in PBMC from cystic fibrosis patients. | 1-gen-2013 | Averna, Monica; Pedrazzi, Marco; Minicucci, Laura; DE TULLIO, Roberta; Cresta, Federico; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon | |
Efficacy of advanced hybrid closed loop systems in cystic fibrosis related diabetes: a pilot study | 1-gen-2024 | Bassi, Marta; Franzone, Daniele; Dufour, Francesca; Spacco, Giordano; Cresta, Federico; D'Annunzio, Giuseppe; Tantari, Giacomo; Calevo, Maria Grazia; Castellani, Carlo; Minuto, Nicola; Casciaro, Rosaria | |
Evidence for alteration of calpain/calpastatin system in PBMC of cystic fibrosis patients | 1-gen-2011 | Averna, Monica; Stifanese, Roberto; DE TULLIO, Roberta; Minicucci, Laura; Cresta, Federico; Palena, Serena; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon | |
Ionocytes and CFTR Chloride Channel Expression in Normal and Cystic Fibrosis Nasal and Bronchial Epithelial Cells | 1-gen-2020 | Scudieri, Paolo; Musante, Ilaria; Venturini, Arianna; Guidone, Daniela; Genovese, Michele; Cresta, Federico; Caci, Emanuela; Palleschi, Alessandro; Poeta, Marco; Santamaria, Francesca; Ciciriello, Fabiana; Lucidi, Vincenzina; Galietta, Luis J V | |
Modulation of Plasmatic Matrix Metalloprotease 9: A Promising New Tool for Understanding the Variable Clinical Responses of Patients with Cystic Fibrosis to Cystic Fibrosis Transmembrane Conductance Regulator Modulators | 1-gen-2023 | Capraro, Michela; Pedrazzi, Marco; DE TULLIO, Roberta; Manfredi, Marcello; Cresta, Federico; Castellani, Carlo; Averna, Monica | |
One-Year Effect of Elexacaftor/Tezacaftor/Ivacaftor Therapy on HbA1c Levels and Insulin Requirement in Patients with Insulin-Dependent Cystic Fibrosis-Related Diabetes: A Retrospective Observational Study | 1-gen-2024 | Bassi, Marta; Strati, Marina Francesca; Spiandorello, Gaia; Scalas, Marta; Cresta, Federico; Calevo, Maria Grazia; D'Annunzio, Giuseppe; Castellani, Carlo; Minuto, Nicola; Maghnie, Mohamad; Casciaro, Rosaria | |
Pathological role of the calpain/calpastatin system in cystic fibrosis | 1-gen-2012 | Averna, Monica; Minicucci, Laura; Palena, S.; Cresta, F.; Pontremoli, Sandro; Melloni, Edon | |
Quantification of Ivacaftor, Tezacaftor and Elexacaftor in plasma of cystic fibrosis patients treated with Kaftrio by a validated liquid chromatography-tandem mass spectrometric (LC-MS/MS) method” | 1-gen-2022 | Cafaro, A.; Pigliasco, F.; Barco, S.; Stella, M.; Pedemonte, N.; Cresta, F.; Casciaro, R.; Castellani, C.; Cangemi, G.; Mattioli, F. | |
QUANTIFICATION OF IVACAFTOR, TEZACAFTOR, AND ELEXACAFTOR IN PLASMA OF CYSTIC FIBROSIS PATIENTS BY AN HPLC–MS/MS METHOD | 1-gen-2023 | Pigliasco, F.; Cafaro, A.; Stella, M.; Baiardi, G.; Barco, S.; Pedemonte, N.; D'Orsi, C.; Cresta, F.; Casciaro, R.; Castellani, C.; Calevo, M. G.; Cangemi, G.; Mattioli, F. | |
Rescue by elexacaftor-tezacaftor-ivacaftor of the G1244E cystic fibrosis mutation's stability and gating defects are dependent on cell background | 1-gen-2023 | Tomati, Valeria; Costa, Stefano; Capurro, Valeria; Pesce, Emanuela; Pastorino, Cristina; Lena, Mariateresa; Sondo, Elvira; Di Duca, Marco; Cresta, Federico; Cristadoro, Simona; Zara, Federico; Galietta, Luis J V; Bocciardi, Renata; Castellani, Carlo; Lucanto, Maria Cristina; Pedemonte, Nicoletta | |
Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients’ Plasma by a Novel LC–MS/MS Method | 1-gen-2023 | Pigliasco, Federica; Cafaro, Alessia; Stella, Manuela; Baiardi, Giammarco; Barco, Sebastiano; Pedemonte, Nicoletta; D'Orsi, Claudia; Cresta, Federico; Casciaro, Rosaria; Castellani, Carlo; Grazia Calevo, Maria; Mattioli, Francesca; Cangemi, Giuliana | |
The calpain-calpastatin system in cystic fibrosis: physiopathological implications | 1-gen-2011 | Averna, Monica; Grosso, R.; Stifanese, Roberto; Cresta, F.; Minicucci, Laura; Melloni, Edon; Pontremoli, Sandro | |
The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs | 1-gen-2022 | Sondo, E.; Cresta, F.; Pastorino, C.; Tomati, V.; Capurro, V.; Pesce, E.; Lena, M.; Iacomino, M.; Baffico, A. M.; Coviello, D.; Bandiera, T.; Zara, F.; Galietta, L. J. V.; Bocciardi, R.; Castellani, C.; Pedemonte, N. | |
The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin | 1-gen-2019 | Furnari, Manuele; De Alessandri, Alessandra; Cresta, Federico; Haupt, Maria; Bassi, Marta; Calvi, Angela; Haupt, Riccardo; Bodini, Giorgia; Ahmed, Iftikhar; Bagnasco, Francesca; Giannini, Edoardo Giovanni; Casciaro, Rosaria | |
Therapeutic monitoring of Ivacaftor, Tezacaftor and Elexacaftor in patients with cystic fibrosis|Monitoraggio terapeutico di Ivacaftor, Tezacaftor e Elexacaftor in pazienti con fibrosi cistica | 1-gen-2023 | Pigliasco, F.; Barco, S.; Pedemonte, N.; Cresta, F.; Casciaro, R.; Castellani, C.; Barbagallo, L.; Maffia, A.; Cangemi, G.; Cafaro, A. | |
Verso un approccio personalizzato per il trattamento del difetto di base in Fibrosi Cistica | 20-mag-2020 | Cresta, Federico |